Predictive value of LCP1 and ADPGK for immune-related adverse events across multiple cancer types in patients receiving immunotherapy-based regimens

Acta Biochimica et Biophysica Sinica 2026 Book chapter Open access

Read full text
Authors: Xi Zhang, Yaqian Li, Li Zhang, Hongyu Liu, Wei Sun, Junhua Li, Dan Xue, Fan Zhang, Yuting Bai, Jing Zhang, Xing Gou, Dongzi Pang
+2 more Xueqin Zeng, Shuqing Wei
DOI: 10.3724/abbs.2026016
Cited by: 0
References: 11

Abstract

Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) and its ligand (PD-L1) have transformed oncology but are frequently compromised by

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Ferroptosis and cancer prognosis

Publication details

Journal / source
Acta Biochimica et Biophysica Sinica
Volume
58
Issue
9
Pages
2139–2143
Publication date
3 February 2026
Language
EN
Document type
Book chapter